10X Genomics Inc
NASDAQ:TXG
10X Genomics Inc
NASDAQ:TXG
Price:
19.19
USD
-1.94%
Market Cap:
$2.4B
Relative Value
The Relative Value of one
TXG
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 19.19 USD,
10X Genomics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TXG Relative Value
HIDDEN
Multiples Across Competitors
TXG Competitors Multiples
10X Genomics Inc Competitors
10X Genomics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
10X Genomics Inc
NASDAQ:TXG
|
2.4B USD | 3.8 | -56.3 | -23.5 | -17.4 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 375.4 | 4 444.8 | 1 409.2 | 3 011 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
192.8B USD | 4.4 | 28.9 | 20.2 | 27.1 | |
| US |
|
Danaher Corp
NYSE:DHR
|
148.3B USD | 6.1 | 41.3 | 22.9 | 34.8 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
137.1T KRW | 14.6 | 50.2 | 50.7 | 67.5 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.8B CHF | 5.7 | 39.2 | 28.7 | 28.7 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
291.5B CNY | 6.6 | 19.4 | 19.7 | 19.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
35.6B USD | 5.1 | 27.4 | 20 | 23.7 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.3B USD | 1.8 | 21 | 11.7 | 17.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28B USD | 7 | 32.2 | 23.8 | 26.4 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
164.6B HKD | 7.3 | 34.7 | 24.4 | 24.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
